Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Down 21.0% in December

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 6,400 shares, a decrease of 21.0% from the December 15th total of 8,100 shares. Based on an average daily volume of 5,500 shares, the days-to-cover ratio is currently 1.2 days.

Lexaria Bioscience Price Performance

LEXXW traded down $0.10 during trading on Thursday, hitting $0.60. 22,501 shares of the company traded hands, compared to its average volume of 8,760. Lexaria Bioscience has a one year low of $0.45 and a one year high of $2.50. The stock’s fifty day moving average is $0.74 and its 200 day moving average is $0.94.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.